ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.26
0.08%
US Tech 100
19,509.19
-0.36%
S&P 500
5,744.01
-0.02%
US Dollar vs CAD
1.35087
0.23%
Bitcoin
66,200.73
1.56%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Scilex Holding Company (SCLX)

  7. Scilex Holding Company (SCLX) News

SCLX

Scilex (SCLX)

Scilex Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCLX
DateTimeSourceHeadlineSymbolCompany
09/26/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025NASDAQ:SCLXScilex Holding Company
09/18/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million LoanNASDAQ:SCLXScilex Holding Company
09/12/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®)NASDAQ:SCLXScilex Holding Company
09/09/20248:00AMGlobeNewswire Inc.Scilex Holding Company to Present at the 26th Annual H.C. Wainwright Global Investment ConferenceNASDAQ:SCLXScilex Holding Company
09/05/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces Acceptance of Presentation at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024NASDAQ:SCLXScilex Holding Company
09/03/20248:24AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
09/03/20248:14AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
09/03/20248:08AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SCLXScilex Holding Company
09/03/20248:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
09/03/20248:00AMGlobeNewswire Inc.Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business CombinationNASDAQ:SCLXScilex Holding Company
08/30/20248:00AMGlobeNewswire Inc.Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024NASDAQ:SCLXScilex Holding Company
08/29/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® LabelNASDAQ:SCLXScilex Holding Company
08/21/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute PainNASDAQ:SCLXScilex Holding Company
08/19/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCLXScilex Holding Company
08/13/20243:34PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
08/13/20243:31PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
08/13/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCLXScilex Holding Company
08/12/20244:07PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SCLXScilex Holding Company
08/09/20248:00AMGlobeNewswire Inc.Scilex Holding Company Enters into Master Distributor Agreement Among CH Trading Group and Devart Middle East for the Distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South AfricaNASDAQ:SCLXScilex Holding Company
08/01/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
08/01/20248:00AMGlobeNewswire Inc.Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended July 31, 2024NASDAQ:SCLXScilex Holding Company
07/25/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCLXScilex Holding Company
07/25/20248:38PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
07/25/20244:28PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
07/25/20244:28PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
07/25/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
07/24/20249:52AMGlobeNewswire Inc.Scilex Holding Company Announces Publication of Its Inaugural Sustainability ReportNASDAQ:SCLXScilex Holding Company
07/23/20248:00AMGlobeNewswire Inc.Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.NASDAQ:SCLXScilex Holding Company
07/18/20243:20PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SCLXScilex Holding Company
07/17/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets inNASDAQ:SCLXScilex Holding Company
 Showing the most relevant articles for your search:NASDAQ:SCLX

Your Recent History

TSXV
TSI
Trench Solutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved